 Chad Camp
Concepts (46)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, N-Methyl-D-Aspartate | 7 | 2023 | 182 | 2.890 |
Why?
| | Parvalbumins | 2 | 2023 | 19 | 1.120 |
Why?
| | Schizophrenia | 2 | 2023 | 418 | 0.800 |
Why?
| | Spasms, Infantile | 1 | 2019 | 105 | 0.610 |
Why?
| | Calcium | 1 | 2023 | 1103 | 0.590 |
Why?
| | Hippocampus | 2 | 2023 | 709 | 0.270 |
Why?
| | Excitatory Amino Acid Antagonists | 2 | 2023 | 89 | 0.230 |
Why?
| | Seizures | 2 | 2023 | 344 | 0.220 |
Why?
| | Neurodevelopmental Disorders | 2 | 2021 | 109 | 0.210 |
Why?
| | Interneurons | 1 | 2023 | 99 | 0.210 |
Why?
| | Receptors, Ionotropic Glutamate | 1 | 2021 | 3 | 0.200 |
Why?
| | Receptors, Glutamate | 1 | 2021 | 19 | 0.200 |
Why?
| | Astrocytes | 1 | 2023 | 163 | 0.190 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2023 | 192 | 0.190 |
Why?
| | Movement Disorders | 1 | 2021 | 46 | 0.190 |
Why?
| | Epilepsy, Generalized | 1 | 2020 | 13 | 0.180 |
Why?
| | Synaptic Transmission | 1 | 2020 | 232 | 0.160 |
Why?
| | Epilepsy | 1 | 2021 | 290 | 0.150 |
Why?
| | Hydrocarbons, Brominated | 1 | 2017 | 5 | 0.140 |
Why?
| | Flame Retardants | 1 | 2017 | 8 | 0.140 |
Why?
| | Dopaminergic Neurons | 1 | 2017 | 43 | 0.140 |
Why?
| | Mice | 4 | 2023 | 15052 | 0.120 |
Why?
| | Animals | 7 | 2023 | 32102 | 0.120 |
Why?
| | Signal Transduction | 2 | 2023 | 4541 | 0.100 |
Why?
| | Dextromethorphan | 2 | 2023 | 19 | 0.100 |
Why?
| | Disease Models, Animal | 1 | 2020 | 3580 | 0.090 |
Why?
| | Infant | 2 | 2020 | 7979 | 0.090 |
Why?
| | Genetic Variation | 2 | 2023 | 878 | 0.070 |
Why?
| | Humans | 7 | 2023 | 115589 | 0.070 |
Why?
| | Xenopus laevis | 1 | 2023 | 118 | 0.050 |
Why?
| | Ketamine | 1 | 2023 | 92 | 0.050 |
Why?
| | Protein Domains | 1 | 2023 | 209 | 0.050 |
Why?
| | Mutation, Missense | 1 | 2023 | 296 | 0.050 |
Why?
| | Neurotransmitter Agents | 1 | 2021 | 77 | 0.050 |
Why?
| | Child | 1 | 2019 | 18489 | 0.050 |
Why?
| | Allosteric Regulation | 1 | 2020 | 84 | 0.050 |
Why?
| | Memantine | 1 | 2020 | 16 | 0.050 |
Why?
| | Gene Knock-In Techniques | 1 | 2020 | 47 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2021 | 213 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 535 | 0.040 |
Why?
| | Central Nervous System | 1 | 2021 | 239 | 0.040 |
Why?
| | Synaptic Potentials | 1 | 2017 | 17 | 0.040 |
Why?
| | alpha-Synuclein | 1 | 2017 | 21 | 0.040 |
Why?
| | Models, Molecular | 1 | 2020 | 1390 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2353 | 0.020 |
Why?
| | Male | 2 | 2020 | 55949 | 0.010 |
Why?
|
|
Camp's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|